Top Story
October 22, 2017
Combination therapy with Sarasar and Norvir in patients with hepatitis D effectively blocked hepatitis D virus production, regardless of Sarasar dose, according to a presentation at The Liver Meeting 2017. Longer treatment duration may clear the virus.
“Up to 20 million people worldwide are infected with hepatitis delta and the majority of them will develop cirrhosis within 5 to 10 years,” Harel Dahari, PhD, from the division of hepatology at the Loyola University Medical Center, Illinois, said in his presentation. “And compared to HBV mono-infected patients, HDV-infected patients will have a higher risk for hepatic decompensation and the development of liver disease.”